V. Cambiano

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
V Cambiano, V. Cambiano, Valentina Cambiano
Publication record
117 papers · 7,048 citations · H-index 41

PAPERS

Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis
20252 citationsauthor #9
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study.
20252 citationsauthor #23
Evidence from high‐income countries on the effectiveness of psychosocial interventions to improve mental health, wellbeing and quality of life for adults living with HIV: a systematic review and meta‐analysis
20255 citationsauthor #12
Human immunodeficiency virus prevention and testing strategies among men who have sex with men in the UK: the PANTHEON research programme including the SELPHI RCT
20240 citationsauthor #10
Thank you to The Lancet Regional Health - Europe's clinical and statistical peer reviewers in 2022
20230 citationsauthor #63
A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study
20234 citationsauthor #9
Estimating the hospital costs of care for people living with HIV in England using routinely collected data
20232 citationsauthor #3
Behaviour changes following HIV diagnosis among men who have sex with men in the era of treatment as prevention: data from a prospective study
20233 citationsauthor #2
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.
20237 citationsauthor #15
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study
202344 citationsauthor #3
The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis
202315 citationsauthor #1
Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study
20235 citationsauthor #2
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models
202215 citationsauthor #12
Estimating the health burden of road traffic injuries in Malawi using an individual-based model
20229 citationsauthor #2
Engagement in HIV services over time among young women who sell sex in Zimbabwe
20224 citationsauthor #9
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa.
20221 citationsauthor #5
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models
202226 citationsauthor #11
Perspectives on the use of modelling and economic analysis to guide HIV programmes in sub-Saharan Africa.
20226 citationsauthor #51
Effectiveness of interventions aimed at reducing HIV acquisition and transmission among gay and bisexual men who have sex with men (GBMSM) in high income settings: A systematic review
202214 citationsauthor #8
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study
202241 citationsauthor #38
Trends in HIV incidence between 2013–2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study
202118 citationsauthor #2
The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
202149 citationsauthor #3
HIV viral load algorithm: what are the needs in the field?: authors' response.
20201 citationsauthor #3
Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study
202032 citationsauthor #2
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
202057 citationsauthor #11
HIV care cascade among female sex workers in Zimbabwe: results of a population-based survey from the Sisters Antiretroviral therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-
20190 citationsauthor #6
How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis
201938 citationsauthor #6
Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study.
201990 citationsauthor #2
Strengthening the scale‐up and uptake of effective interventions for sex workers for population impact in Zimbabwe
201947 citationsauthor #8
Cost‐per‐diagnosis as a metric for monitoring cost‐effectiveness of HIV testing programmes in low‐income settings in southern Africa: health economic and modelling analysis
201933 citationsauthor #2
Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance
201932 citationsauthor #2
The impact and cost‐effectiveness of community‐based HIV self‐testing in sub‐Saharan Africa: a health economic and modelling analysis
201981 citationsauthor #1
Optimizing HIV testing services in sub‐Saharan Africa: cost and performance of verification testing with HIV self‐tests and tests for triage
201911 citationsauthor #3
BHIVA/BASHH guidelines on the use of HIV pre–exposure prophylaxis (PrEP) 2018
201997 citationsauthor #4
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
2019768 citationsauthor #2
Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment
201933 citationsauthor #5
Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
201938 citationsauthor #3
Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trial.
201894 citationsauthor #7
The HIV care cascade among female sex workers in Zimbabwe: 1 results of a population-based survey from the Sisters
20182 citationsauthor #6
Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
2018148 citationsauthor #1
Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–2016
201877 citationsauthor #2
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
2018109 citationsauthor #11
RESULTS OF THE SAPPHIRE TRIAL : A CLUSTER RANDOMISED TRIAL OF A COMPREHENSIVE TARGETTED COMBINATION PREVENTION INTERVENTION TO SUPPORT FEMALE SEX WORKERS IN ZIMBABWE TO LINK AND ADHERE TO ANTIRETROVIRALS FOR TREATMENT AND PREVENTION
20181 citationsauthor #7
Trends in engagement in the HIV prevention and the care cascade among young women who sell sex in Zimbabwe
20180 citationsauthor #4
Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care
201821 citationsauthor #3
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations initiating therapy : modelling study and economic analysis
20180 citationsauthor #2
90‐90‐90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe – 2017 to 2020
20188 citationsauthor #2
COST-EFFECTIVENESS OF DIFFERENT DELIVERY APPROACHES FOR HIV SELF-TESTING
20173 citationsauthor #1
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
201772 citationsauthor #2
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
201772 citationsauthor #28
Eligibility for PrEP among MSM attending GUM clinics in the UK
20172 citationsauthor #2
Implications for a policy of initiating antiretroviral therapy in people diagnosed with human immunodeficiency virus: the CAPRA research programme
20172 citationsauthor #4
Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics.
2017199 citationsauthor #4
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
201759 citationsauthor #5
Is Pre-Exposure Prophylaxis for HIV prevention cost-effective in men who have sex with men in the UK? A modelling and health economic evaluation
20172 citationsauthor #1
The HIV Care Cascade Among Female Sex Workers in Zimbabwe: Results of a Population-Based Survey From the Sisters Antiretroviral Therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial
201787 citationsauthor #6
Guideline writing group Michael Brady (co-Chair) Consultant in Sexual Health & HIV, King’s College Hospital
20170 citationsauthor #3
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
2017113 citationsauthor #3
BHIVA – BASHH Position Statement on PrEP in UK Second Update May 2016
201612 citationsauthor #7
Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa
201621 citationsauthor #2
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
20161,293 citationsauthor #2
Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile
201625 citationsauthor #2
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa
20167 citationsauthor #499
What do we know about the cost–effectiveness of HIV preexposure prophylaxis, and is it affordable?
201639 citationsauthor #1
Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study)
201613 citationsauthor #4
Statistical design and analysis plan for an impact evaluation of an HIV treatment and prevention intervention for female sex workers in Zimbabwe: a study protocol for a cluster randomised controlled trial
201627 citationsauthor #5
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
201614 citationsauthor #2
Brief overview of cost-effectiveness of PrEP
20162 citationsauthor #1
Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era.
201553 citationsauthor #4
O1 Is pre-exposure prophylaxis for hiv prevention cost-effective in men who have sex with men who engage in condomless sex in the uk?
201524 citationsauthor #1
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
201512 citationsauthor #6
Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries
201568 citationsauthor #1
Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
201555 citationsauthor #2
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
2015160 citationsauthor #10
Updated BHIVA-BASHH Position Statement on PrEP in the UK
20156 citationsauthor #7
Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting
201420 citationsauthor #2
The accuracy of respiratory rate assessment by doctors in a London teaching hospital: a cross-sectional study
201481 citationsauthor #3
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
201432 citationsauthor #2
The importance of HIV RNA detection below 50 copies per mL in HIV-positive patients on antiretroviral therapy: an observational study
20144 citationsauthor #4
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis.
201442 citationsauthor #2
Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.
201452 citationsauthor #7
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
2014214 citationsauthor #4
Insights from an individual-level model of HIV programmes in southern Africa : HIV testing, ART and resistance
20140 citationsauthor #1
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation
201459 citationsauthor #1
Modelling the Potential Population Impact and Cost-Effectiveness of Self-Testing for HIV: Evaluation of Data Requirements
201426 citationsauthor #1
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
201333 citationsauthor #4
How should HIV programmes respond to evidence for the benefits of earlier treatment initiation ? A combined analysis of twelve mathematical models
20139 citationsauthor #4
Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic
2013234 citationsauthor #2
How Should HIV Programmes Monitor Adults on ART? A Combined Analysis of Three Mathematical Models
20136 citationsauthor #7
Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings.
201382 citationsauthor #1
Persistence of HIV-1 Transmitted Drug Resistance Mutations
2013106 citationsauthor #5
Antiretroviral therapy for prevention of HIV transmission: implications for Europe.
201323 citationsauthor #1
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models
201376 citationsauthor #5
Influenza and pneumococcal vaccinations in dialysis patients in a London district general hospital
201314 citationsauthor #3
Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
201215 citationsauthor #2
Pre-exposure prophylaxis (PrEP) will have a limited impact on the prevalence of HIV-1 drug resistance in sub-Saharan Africa: comparison of mathematical models
20122 citationsauthor #4
TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona
20120 citationsauthor #803
Projected life expectancy of people with HIV according to timing of diagnosis
2012454 citationsauthor #5
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy.
2012162 citationsauthor #4
Projected Lifetime Healthcare Costs Associated with HIV Infection
201258 citationsauthor #6

TIMELINE

2007 1 citations

2008 2 citations

2009 2 citations

2010 145 citations

2011 156 citations

2012 1,102 citations

2013 583 citations

2014 530 citations

2015 378 citations

2016 1,453 citations

2017 539 citations

2018 460 citations

2019 1,268 citations

2020 90 citations

2021 67 citations

2022 116 citations

2023 80 citations

2024 0 citations

2025 9 citations

V. Cambiano

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT